The First Use Of A Live Listeria Cancer Vaccine In Humans

April 16th, 2008 | Category: Cancer

Phase I/II trial results have shown that the live Listeria cancer vaccine, Lovaxin C, is safe for humans. In addition, three women in the cervical cancer trial had approximately 20 percent tumor reductions, researchers report. “We are using

Listeria to deliver tumor-specific antigens to the immune system in a manner that results in maximal immune and tumor-clearing response,” said John Rothman, Ph.D.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Advaxis Scientists Publish Research Of Listeria Monocytogenes-Based Vaccine For Prostate Cancer In Latest Edition Of Cancer Immunology & Immunotherapy
  • The Cancer Research Institute Unites Cancer Vaccine Consortium And Cancer Vaccine Collaborative
  • Department Of Health Awards Contract For HPV Vaccine
  • GSK Cervical Cancer Vaccine Demonstrates Protection For Up To 6.4 Years, Latest details Shows
  • Smokers Offered Special Insurance Policy considering They Die Earlier

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.